XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - UNAUDITED - USD ($)
$ in Thousands
Total
Revision of Prior Period, Accounting Standards Update, Adjustment
Common Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Revision of Prior Period, Accounting Standards Update, Adjustment
Accumulated Other Comprehensive Income/ (Loss)
Balance at beginning of period at Dec. 31, 2018 $ 1,067,903   $ 35,531 $ 606,573 $ 441,553   $ (15,754)
Net income 87,976       87,976    
Other comprehensive income, net of tax 13,046           13,046
Total comprehensive income 101,022            
Common stock dividends (31,509)       (31,509)    
Stock compensation expense 2,259     2,259      
Stock option plan 259   12 247      
Director's stock purchase plan 30   1 29      
Employee stock purchase plan 779   27 752      
Restricted stock, net (702)   55 (757)      
Balance at end of period at Sep. 30, 2019 1,140,041   35,626 609,103 498,020   (2,708)
Balance at beginning of period at Jun. 30, 2019 1,119,445   35,615 608,006 479,389   (3,565)
Net income 29,383       29,383    
Other comprehensive income, net of tax 857           857
Total comprehensive income 30,240            
Common stock dividends (10,752)       (10,752)    
Stock compensation expense 786     786      
Stock option plan 35   1 34      
Employee stock purchase plan 287   10 277      
Balance at end of period at Sep. 30, 2019 1,140,041   35,626 609,103 498,020   (2,708)
Balance at beginning of period at Dec. 31, 2019 1,132,974   34,970 586,622 515,714   (4,332)
Net income 40,291       40,291   0
Other comprehensive income, net of tax 21,825           21,825
Total comprehensive income 62,116            
Common stock dividends (38,953)       (38,953)    
Stock compensation expense 2,824     2,824 0    
Revere Bank acquisition 289,089   12,769 276,320      
Stock option plan 165   11 154      
Conversion of Revere stock options 3,611   0 3,611      
Employee stock purchase plan 1,309   50 1,259      
Restricted stock, net (463)   46 (509)      
Adoption of ASC 326 - Financial Instruments - Credit Losses   $ (2,221)       $ (2,221)  
Repurchase of common stock - 820,328 shares (25,702)   (820) (24,882)      
Balance at end of period at Sep. 30, 2020 1,424,749   47,026 845,399 514,831   17,493
Balance at beginning of period at Jun. 30, 2020 1,390,093   47,001 843,876 484,392   14,824
Net income 44,642       44,642    
Other comprehensive income, net of tax 2,669           2,669
Total comprehensive income 47,311            
Common stock dividends (14,205)       (14,205)    
Stock compensation expense 1,032     1,032      
Stock option plan 18   2 16      
Employee stock purchase plan 524   21 503      
Restricted stock, net (26)   2 (28)      
Adoption of ASC 326 - Financial Instruments - Credit Losses   $ 2       $ 2  
Balance at end of period at Sep. 30, 2020 $ 1,424,749   $ 47,026 $ 845,399 $ 514,831   $ 17,493
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member